DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+9.67%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$22.5B
AUM Growth
+$6.7B
(+42%)
Cap. Flow
+$5.41B
Cap. Flow
% of AUM
23.99%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
1,250
New
219
Increased
672
Reduced
222
Closed
62
Top Buys
| 1 |
Amazon
AMZN
|
$153M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$137M |
| 3 |
Amgen
AMGN
|
$98.9M |
| 4 |
NVIDIA
NVDA
|
$95.9M |
| 5 |
Linde
LIN
|
$94.8M |
Top Sells
| 1 |
B
Barrick Mining Corporation
B
|
$26.2M |
| 2 |
Evergy
EVRG
|
$16.3M |
| 3 |
Wells Fargo
WFC
|
$12.3M |
| 4 |
Exxon Mobil
XOM
|
$11.3M |
| 5 |
Philip Morris
PM
|
$11.2M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Healthcare | 17.04% |
| 3 | Financials | 10.86% |
| 4 | Communication Services | 10.43% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
NETSCOUT
NTCT
$1.79B
| $516K | ﹤0.01% |
23,640
| – | – |
|
927
Karyopharm Therapeutics
KPTI
$57.2M
| $515K | ﹤0.01% |
+2,413
| New | +$515K |
|
928
Live Nation Entertainment
LYV
$37.9B
| $515K | ﹤0.01% |
9,765
-866
| -8% | -$45.7K |
|
929
Theravance Biopharma
TBPH
$703M
| $515K | ﹤0.01% |
34,550
+25,636
| +288% | +$382K |
|
930
Atlassian
TEAM
$45.2B
| $512K | ﹤0.01% |
2,828
-3,017
| -52% | -$546K |
|
931
Guidewire Software
GWRE
$22B
| $507K | ﹤0.01% |
4,938
+357
| +8% | +$36.7K |
|
932
White Mountains Insurance
WTM
$4.63B
| $505K | ﹤0.01% |
+662
| New | +$505K |
|
|
WMGI
933
DELISTED
Wright Medical Group Inc
WMGI
| $505K | ﹤0.01% |
17,000
+6,000
| +55% | +$178K |
|
934
Omega Healthcare
OHI
$12.7B
| $503K | ﹤0.01% |
17,361
-3,033
| -15% | -$87.9K |
|
935
Thor Industries
THO
$5.94B
| $502K | ﹤0.01% |
5,300
| – | – |
|
936
Tencent Music
TME
$37.7B
| $500K | ﹤0.01% |
34,118
+17,958
| +111% | +$263K |
|
|
NBL
937
DELISTED
Noble Energy, Inc.
NBL
| $500K | ﹤0.01% |
59,249
-351,941
| -86% | -$2.97M |
|
938
NOV
NOV
$4.95B
| $497K | ﹤0.01% |
54,316
+20,349
| +60% | +$186K |
|
939
RenaissanceRe
RNR
$11.3B
| $497K | ﹤0.01% |
2,961
+187
| +7% | +$31.4K |
|
940
Stepan Co
SCL
$1.13B
| $493K | ﹤0.01% |
+4,598
| New | +$493K |
|
941
Invesco
IVZ
$9.81B
| $489K | ﹤0.01% |
42,074
-106,490
| -72% | -$1.24M |
|
942
Veracyte
VCYT
$2.55B
| $489K | ﹤0.01% |
+15,100
| New | +$489K |
|
943
Genpact
G
$7.82B
| $486K | ﹤0.01% |
12,714
| – | – |
|
944
Avantor
AVTR
$9.07B
| $483K | ﹤0.01% |
21,884
+1,146
| +6% | +$25.3K |
|
945
NNN REIT
NNN
$8.18B
| $481K | ﹤0.01% |
14,054
-3,290
| -19% | -$113K |
|
|
MNDT
946
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $480K | ﹤0.01% |
38,950
| – | – |
|
947
Aramark
ARMK
$10.2B
| $476K | ﹤0.01% |
25,528
-3,662
| -13% | -$68.3K |
|
948
Compugen
CGEN
$134M
| $475K | ﹤0.01% |
+30,000
| New | +$475K |
|
949
Dayforce
DAY
$10.9B
| $460K | ﹤0.01% |
5,682
+1,982
| +54% | +$160K |
|
|
ICPT
950
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $457K | ﹤0.01% |
+11,090
| New | +$457K |
|